• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 2, 2006

View Archived Issues

TMC-114 plus ritonavir safe in HIV-hepatitis coinfection

Read More

R-1626 shows promise in hepatitis C

Read More

AEE-788 investigated in hepatocellular carcinoma

Read More

Pentoxifylline assessed in clinical trials in liver diseases

Read More

Platrol, a safe sustained release antiplatelet drug

Read More

CTT Cancer Targeting Technologies and Karyon to merge

Read More

Crofelemer studied for D-IBS in new phase IIb trial

Read More

Stelic discovers new treatment approach for acute liver failure

Read More

Acenta and NCI collaborate on novel Akt inhibitors for cancer

Read More

Adherex and SIOPEL sign in support of phase III oroprotectant study of STS

Read More

Novel antiinfective agents disclosed in recent patent literature

Read More

New therapeutic agents for gastrointestinal disorders disclosed in recent patents

Read More

Novel agents for fibrotic disorders patented

Read More

Novel CYP2A inhibitors for smoking cessation patented by InflaZyme

Read More

Novel cannabinoid agonists reported by Adolor

Read More

Satori Pharmaceuticals' SPI-014 exhibits Abeta42-lowering activity in vitro and in vivo

Read More

Secretin studied for utility in functional MRI of the pancreas

Read More

Ribose shows potential in CHF patients

Read More

Genasense: NDA review extended in CLL, pivotal enrollment completed in AML

Read More

MB-07811 studied in phase I for management of hyperlipidemia

Read More

NG2-73 begins phase II study in chronic insomnia patients

Read More

BIW-8405 begins phase I trial for asthma

Read More

Albany Molecular Research advances oncology candidate towards IND filing

Read More

Merck & Co. to acquire Sirna Therapeutics

Read More

RP-101 cleared to begin phase II study in pancreatic cancer

Read More

Advexin to be filed under EMEA Exceptional Circumstances rules

Read More

Tesofensine cleared for phase I/II metabolic study

Read More

Phase II findings for U-101 in chronic pelvic pain of bladder origin

Read More

Emerging natural products for the treatment of neurological disorders: Part II

Read More

Emisphere's oral insulin shows efficacy in type 2 diabetes patients

Read More

FDA approval for Polyphenon E Ointment

Read More

Approvable letter for Zenvia

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe